脓毒症与脓毒性休克
脓毒症病死率高,存活者常遗留长期并发症。2017年世界卫生大会和WHO将脓毒症列为全球健康优先事项并通过决议改善其预防、诊断和管理。2016年提出Sepsis-3新定义,将脓毒症定义为感染伴器官功能障碍,用序贯器官衰竭评估(SOFA)评分量化器官功能障碍。目前研究致力于细化患者人群以实现个体化治疗、寻找改善诊断的技术及可改变病程的药物;在等待这些目标实现期间,通过教育和质量改进项目改善基础诊疗是提高良好结局的最大希望。
要点
- Sepsis-3(2016年)将脓毒症定义为感染伴器官功能障碍,用SOFA评分量化器官功能障碍。
- 2017年世界卫生大会和WHO将脓毒症列为全球健康优先事项,并通过决议改善其预防、诊断和管理。
- 脓毒症病死率高,许多存活者存在长期并发症。
- 目前尚无能通过改变疾病过程改善结局的药物,仍在寻找中。
- 通过教育和质量改进项目改善基础诊疗,是当前提高良好结局的最大希望。
诊断标准与关键阈值
- Sepsis-3(2016年)定义:脓毒症为感染伴器官功能障碍,用序贯器官衰竭评估(SOFA)评分量化器官功能障碍。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在等待个体化管理和改善病程的药物研究目标实现期间,通过教育和质量改进项目改善基础诊疗是提高良好结局的最大希望。
指南或共识出处
- 世界卫生大会和WHO于2017年通过决议,将脓毒症列为全球健康优先事项并改善其预防、诊断和管理。
- Sepsis-3(2016年)脓毒症新定义。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「处置流程与药物剂量」「红旗征与不能漏的情况」「研究设计与关键结果」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis is a common condition that is associated with unacceptably high mortality and, for many of those who survive, long-term morbidity. Increased awareness of the condition resulting from ongoing campaigns and the evidence arising from research in the past 10 years have increased understanding of this problem among clinicians and lay people, and have led to improved outcomes. The World Health Assembly and WHO made sepsis a global health priority in 2017 and have adopted a resolution to improve the prevention, diagnosis, and management of sepsis. In 2016, a new definition of sepsis (Sepsis-3) was developed. Sepsis is now defined as infection with organ dysfunction. This definition codifies organ dysfunction using the Sequential Organ Failure Assessment score. Ongoing research aims to improve definition of patient populations to allow for individualised management strategies matched to a patient's molecular and biochemical profile. The search continues for improved diagnostic techniques that can facilitate this aim, and for a pharmacological agent that can improve outcomes by modifying the disease process. While waiting for this goal to be achieved, improved basic care driven by education and quality-improvement programmes offers the best hope of increasing favourable outcomes.
参考来源
- Cecconi M, Evans L, Levy M, et al. Sepsis and septic shock. Lancet. 2018. PMID: 29937192. doi:10.1016/S0140-6736(18)30696-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。